BRAF mutated melanoma: targeted or immunotherapy?
Rodabe N. Amaria
Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma
Psycho-oncology: measuring levels of emotional distress in cancer patients and their families
The future of cutaneous T-cell lymphoma treatment
Overview of the CONVERT trial in LS-SCLC